These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 31468449)

  • 21. Influences of different developmental periods of taurine supplements on synaptic plasticity in hippocampal CA1 area of rats following prenatal and perinatal lead exposure.
    Yu SS; Wang M; Li XM; Chen WH; Chen JT; Wang HL; Ruan DY
    BMC Dev Biol; 2007 May; 7():51. PubMed ID: 17511882
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Short-term effects of a perinatal exposure to the HBCDD α-isomer in rats: Assessment of early motor and sensory development, spontaneous locomotor activity and anxiety in pups.
    Maurice N; Olry JC; Cariou R; Dervilly-Pinel G; Le Bizec B; Travel A; Jondreville C; Schroeder H
    Neurotoxicol Teratol; 2015; 52(Pt B):170-80. PubMed ID: 26348671
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CNS effects of developmental Pb exposure are enhanced by combined maternal and offspring stress.
    Virgolini MB; Rossi-George A; Lisek R; Weston DD; Thiruchelvam M; Cory-Slechta DA
    Neurotoxicology; 2008 Sep; 29(5):812-27. PubMed ID: 18440644
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of taurine on rat behaviors in three anxiety models.
    Kong WX; Chen SW; Li YL; Zhang YJ; Wang R; Min L; Mi X
    Pharmacol Biochem Behav; 2006 Feb; 83(2):271-6. PubMed ID: 16540157
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neurobehavioral effects of lead and manganese individually and in combination in developmentally exposed rats.
    Betharia S; Maher TJ
    Neurotoxicology; 2012 Oct; 33(5):1117-27. PubMed ID: 22732189
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intermittent low-level lead exposure provokes anxiety, hypertension, autonomic dysfunction and neuroinflammation.
    Shvachiy L; Geraldes V; Amaro-Leal Â; Rocha I
    Neurotoxicology; 2018 Dec; 69():307-319. PubMed ID: 30098355
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Performance in anxiety and spatial memory tests following bilateral vestibular loss in the rat and effects of anxiolytic and anxiogenic drugs.
    Zheng Y; Cheung I; Smith PF
    Behav Brain Res; 2012 Nov; 235(1):21-9. PubMed ID: 22824589
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alterations in glucocorticoid negative feedback following maternal Pb, prenatal stress and the combination: a potential biological unifying mechanism for their corresponding disease profiles.
    Rossi-George A; Virgolini MB; Weston D; Cory-Slechta DA
    Toxicol Appl Pharmacol; 2009 Jan; 234(1):117-27. PubMed ID: 18977374
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anxiolytic actions of Nardostachys jatamansi via GABA benzodiazepine channel complex mechanism and its biodistribution studies.
    Razack S; Kandikattu HK; Venuprasad MP; Amruta N; Khanum F; Chuttani K; Mishra AK
    Metab Brain Dis; 2018 Oct; 33(5):1533-1549. PubMed ID: 29934858
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacological evaluation of the anxiolytic-like effects of EMD 386088, a partial 5-HT6 receptor agonist, in the rat elevated plus-maze and Vogel conflict tests.
    Jastrzębska-Więsek M; Siwek A; Partyka A; Kubacka M; Mogilski S; Wasik A; Kołaczkowski M; Wesołowska A
    Neuropharmacology; 2014 Oct; 85():253-62. PubMed ID: 24905144
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lead-induced alterations of glial fibrillary acidic protein (GFAP) in the developing rat brain.
    Harry GJ; Schmitt TJ; Gong Z; Brown H; Zawia N; Evans HL
    Toxicol Appl Pharmacol; 1996 Jul; 139(1):84-93. PubMed ID: 8685912
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anxiolytic effects of yokukansan, a traditional Japanese medicine, via serotonin 5-HT1A receptors on anxiety-related behaviors in rats experienced aversive stress.
    Yamaguchi T; Tsujimatsu A; Kumamoto H; Izumi T; Ohmura Y; Yoshida T; Yoshioka M
    J Ethnopharmacol; 2012 Sep; 143(2):533-9. PubMed ID: 22819689
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Strychnine and taurine modulation of amygdala-associated anxiety-like behavior is 'state' dependent.
    McCool BA; Chappell A
    Behav Brain Res; 2007 Mar; 178(1):70-81. PubMed ID: 17207866
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of ventral hippocampal GABA(A) and NMDA receptors in the anxiolytic effect of carbamazepine in rats using the elevated plus maze test.
    Rezvanfard M; Zarrindast MR; Bina P
    Pharmacology; 2009; 84(6):356-66. PubMed ID: 19907194
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anxiogenic effects of neurosteroid exposure: sex differences and altered GABAA receptor pharmacology in adult rats.
    Gulinello M; Smith SS
    J Pharmacol Exp Ther; 2003 May; 305(2):541-8. PubMed ID: 12606703
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anxiolytic-like effects of nociceptin/orphanin FQ in the elevated plus maze and in the conditioned defensive burying test in rats.
    Vitale G; Arletti R; Ruggieri V; Cifani C; Massi M
    Peptides; 2006 Sep; 27(9):2193-200. PubMed ID: 16730097
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of low level maternal Pb exposure and prenatal stress on offspring stress challenge responsivity.
    Virgolini MB; Rossi-George A; Weston D; Cory-Slechta DA
    Neurotoxicology; 2008 Nov; 29(6):928-39. PubMed ID: 18951918
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sex differences in anxiety-like behavior and locomotor activity following prenatal and postnatal methamphetamine exposure in adult rats.
    Hrubá L; Schutová B; Šlamberová R
    Physiol Behav; 2012 Jan; 105(2):364-70. PubMed ID: 21884713
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oral buspirone causes a shift in the dose-response curve between the elevated-plus maze and Vogel conflict tests in Long-Evans rats: relation of brain levels of buspirone and 1-PP to anxiolytic action.
    Vaidya AH; Rosenthal DI; Lang W; Crooke JJ; Benjamin D; Ilyin SE; Reitz AB
    Methods Find Exp Clin Pharmacol; 2005 May; 27(4):245-55. PubMed ID: 16082425
    [TBL] [Abstract][Full Text] [Related]  

  • 40. One-trial tolerance to the effects of chlordiazepoxide in the elevated plus-maze is not due to acquisition of a phobic avoidance of open arms during initial exposure.
    Frussa-Filho R; Ribeiro Rde A
    Life Sci; 2002 Jun; 71(5):519-25. PubMed ID: 12052436
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.